Drug Delivery Systems based on NanotechnologyAuthor(s): Amelia Hawking
Nanotechnology has been shown to bridge the gap between biological and physical sciences by employing nanostructures and nanophases in a variety of fields, including nanomedicine and nano-based drug delivery systems, where such particles are of particular interest. Nanomaterials are materials of sizes ranging from 1 nm to 100 nm that impact the frontiers of nanomedicine, from biosensors to microfluidics, drug delivery, and microarray experiments to tissue engineering. To build nanomedicines, nanotechnology hires curative agents at the nanoscale stage. Nanoparticles also fueled the world of biomedicine, which includes nanobiotechnology, drug delivery, biosensors, and tissue engineering. Nanoparticles are usually thin nanospheres made up of materials engineered at the atomic or molecular level. As a result, they can travel more naturally inside the human body than larger materials. The structural, chemical, electronic, magnetic, electrical, and biological properties of nanoscale particles are all distinct. Nanomedicines have gained popularity in recent years as a result of their ability to encapsulate drugs or bind therapeutic drugs to nanostructures and distribute them to target tissues more accurately and with a controlled release.